RPG Life Sciences Ltd Q4 FY2024 PAT falls QoQ to Rs. 13.24 crores

RPG Life Sciences Limited has reported Standalone financial results for the period ended March 31, 2024.

Financial Results (Q4 FY2024) - QoQ Comparison

The company has reported total income of Rs. 128.64 crores during the period ended March 31, 2024 as compared to Rs. 155.62 crores during the period ended December 31, 2023.

The company has posted net profit / (loss) of Rs. 13.24 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs. 26.46 crores for the period ended December 31, 2023.

The company has reported EPS of Rs. 8.01 for the period ended March 31, 2024 as compared to Rs. 16 for the period ended December 31, 2023.

Financials	Q4 FY2024	Q3 FY2024	% Change
Total Income	₹128.64 crs	₹155.62 crs	-17.34%
Net Profit	₹13.24 crs	₹26.46 crs	-49.96%
EPS	₹8.01	₹16	-49.94%

Financial Results (Q4 FY2024) - YoY Comparison

The company has reported total income of Rs.128.64 crores during the period ended March 31, 2024 as compared to Rs.120.33 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs.13.24 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs.10.35 crores for the period ended March 31, 2023.

The company has reported EPS of Rs.8.01 for the period ended March 31, 2024 as compared to Rs.6.26 for the period ended March 31, 2023.

Financials	Q4 FY2024	Q4 FY2023	% Change
Total Income	₹128.64 crs	₹120.33 crs	6.91%
Net Profit	₹13.24 crs	₹10.35 crs	27.92%
EPS	₹8.01	₹6.26	27.96%

Financial Results (Year Ended FY2024) - YoY Comparison

The company has reported total income of Rs.589.26 crores during the Financial Year ended March 31, 2024 as compared to Rs.517.61 crores during the Financial Year ended March 31, 2023.

The company has posted net profit / (loss) of Rs.87.66 crores for the Financial Year ended March 31, 2024 as against net profit / (loss) of Rs.67.64 crores for the Financial Year ended March 31, 2023.

The company has reported EPS of Rs.53.01 for the Financial Year ended March 31, 2024 as compared to Rs.40.90 for the Financial Year ended March 31, 2023.

Financials	Year Ended FY2024	Year Ended FY2023	% Change
Total Income	₹589.26 crs	₹517.61 crs	13.84%
Net Profit	₹87.66 crs	₹67.64 crs	29.60%
EPS	₹53.01	₹40.90	29.61%

Shares of RPG Life Sciences Limited was last trading in BSE at Rs. 1553.00 as compared to the previous close of Rs. 1558.60. The total number of shares traded during the day was 1246 in over 246 trades.

The stock hit an intraday high of Rs. 1589.95 and intraday low of 1545.00. The net turnover during the day was Rs. 1940081.00.

Source : Equity Bulls

Keywords

RPGLifeSciences Q4FY24 FY2024 ResultUpdate